|1.||Jiang, Shibo: 4 articles (11/2013 - 04/2011)|
|2.||Li, Lin: 4 articles (11/2013 - 04/2011)|
|3.||Qiu, Jiayin: 2 articles (11/2013 - 03/2013)|
|4.||Yu, Fei: 2 articles (11/2013 - 01/2013)|
|5.||Lu, Lu: 2 articles (03/2013 - 04/2011)|
|6.||Liu, Shuwen: 2 articles (03/2013 - 04/2011)|
|7.||Duan, Jiangman: 1 article (11/2013)|
|8.||Li, Minmin: 1 article (11/2013)|
|9.||Che, Xiaoyan: 1 article (11/2013)|
|10.||An, Shengli: 1 article (03/2013)|
08/01/1997 - "Glycodelins GdA and GdS modified by 3-hydroxyphthalic anhydride inhibit gp120-CD4 binding and HIV-1 infection in vitro."
11/01/2013 - "We previously reported that 3-hydroxyphthalic anhydride-modified human serum albumin (HP-HSA) as an anti-HIV microbicide could potently inhibit infection by a broad spectrum of HIV-1 strains; however, its mechanism of action is still elusive. "
01/01/2013 - "Furthermore, one small molecule HIV entry inhibitor targeting gp41 (ADS-J1) and the 3-hydroxyphthalic anhydride-modified human serum albumin (HP-HSA) could significantly inhibit MERS-CoV pseudovirus infection. "
04/15/2011 - "Combinations of 3-hydroxyphthalic anhydride-modified ovalbumin with antiretroviral drug-based microbicide candidates display synergistic and complementary effects against HIV-1 infection."
04/01/1999 - "Bovine beta-lactoglobulin modified by 3-hydroxyphthalic anhydride (3-hydroxyphthalovyl-beta-lactoglobulin [3HP-beta-LG]) was shown to inhibit HIV-1, HIV-2, simian immunodeficiency virus (SIV), herpes simplex virus type 1 and 2, and Chlamydia trachomatis infection in vitro. "
|2.||HIV Infections (HIV Infection)
|4.||Proteins (Proteins, Gene)
|5.||Membrane Glycoproteins (Membrane Glycoprotein)
|6.||Maleic Anhydrides (Maleic Anhydride)